English

KEMPHARM, INC

EDGAR

KMPH Quarterly report (10-Q) · filed 2026-08-05

60 filing records in this dataset, filed from 2015-03-11 to 2026-08-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2016 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-3.87 million USD

2016 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3865000 USD Source

Free cash flow

-3.93 million USD

2016 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3865000 USD Source
Capital Expenditure: 66000 USD Source

Cash and cash equivalents: 145 million USD 2026-06-30 Source
Exact value

145321000 USD
Long-term debt including current maturities: 61.9 million USD 2025-12-31 Source
Exact value

61928000 USD
Shares outstanding: 59.3 million shares 2026-06-30 Source
Exact value

59341906 shares

Reported share-count change

7.73% · 4.26 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

55084204 shares · 2025-06-30· Source
59341906 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Revenue: 0 USD · 2015-04-01 – 2015-06-30 Source
Revenue: 0 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 0 USD · 2015-10-01 – 2015-12-31 Source
Revenue: 0 USD · 2016-01-01 – 2016-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2015-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2025-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 188.74 million

Prior period

−USD 105.51 million

2024-01-01 – 2024-12-31
Current period

USD 83.23 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

83229000 − -105511000 = 188740000 USD

-105511000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
83229000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Year-over-year change in Net income: 188740000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 83229000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1636837 Filing: 000143464726000011 Input fundies:NetIncome: -105511000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1637606 Filing: 000143464726000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 68.07 million

Prior period

−USD 69.67 million

2024-01-01 – 2024-12-31
Current period

−USD 1.6 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-1598000 − -69665000 = 68067000 USD

-69665000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-1598000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Year-over-year change in Operating cash flow: 68067000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1598000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1047540 Filing: 000143464726000011 Input fundies:OperatingCashFlow: -69665000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1048191 Filing: 000143464726000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 835,000

Prior period

USD 0

2024-01-01 – 2024-12-31
Current period

USD 835,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

835000 − 0 = 835000 USD

0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
835000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Year-over-year change in Capital expenditure: 835000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 835000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1049826 Filing: 000143464726000011 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1050384 Filing: 000143464726000011
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 0
Operating costs Derived USD 22.81 million
Operating income −USD 22.81 million
Tax, interest and other Derived USD 31.85 million
Net income −USD 54.66 million

Cash

Operating cash flow −USD 20.27 million
Capital expenditure USD 135,000
Free cash flow Derived −USD 20.4 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	0	22814000 Derived	-22814000	31850000 Derived	-54664000	-20403000 Derived	Source 2015-01-01 – 2015-12-31: 0 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -22814000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -54664000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -20268000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 135000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	Not reported	Operating Income: -22814000 Open source Revenue: 0 Open source
20152015-12-31	Net margin	Not reported	Net Income: -54664000 Open source Revenue: 0 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -20268000 Open source Capital Expenditure: 135000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -20.3M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-20268000	Operating Cash Flow: -20268000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -20.4M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-20403000	Operating Cash Flow: -20268000 Open source Capital Expenditure: 135000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

118.5% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	118.5%	Total Liabilities: 64711000 Open source Total Assets: 54590000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.48× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	6.48×	Current Assets: 54078000 Open source Current Liabilities: 8342000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 54.66 million Exact value Exact value: -54664000 USD 2015-01-01 – 2015-12-31: -54664000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2015-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -54664000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54664000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000156459016014881/kmph-20151231.xml#191682 Filing: 000156459016014881 The citation records this snapshot. The page link may show a newer release later.	−USD 20.27 million Exact value Exact value: -20268000 USD 2015-01-01 – 2015-12-31: -20268000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2015-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -20268000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20268000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000156459016014881/kmph-20151231.xml#211711 Filing: 000156459016014881 The citation records this snapshot. The page link may show a newer release later.	USD 135,000 Exact value Exact value: 135000 USD 2015-01-01 – 2015-12-31: 135000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2015-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 135000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000156459016014881/kmph-20151231.xml#212849 Filing: 000156459016014881 The citation records this snapshot. The page link may show a newer release later.	−USD 20.4 million Calculation and evidence -20268000 − 135000 USD Exact free cash flow: -20403000 USD 2015-01-01 – 2015-12-31: -20268000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 135000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2015-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -20403000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20268000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000156459016014881/kmph-20151231.xml#211711 Filing: 000156459016014881 Input fundies:CapitalExpenditure: 135000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000156459016014881/kmph-20151231.xml#212849 Filing: 000156459016014881 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 56.47 million Exact value Exact value: -56466000 USD 2018-01-01 – 2018-12-31: -56466000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2018-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -56466000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56466000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491627 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	−USD 54.2 million Exact value Exact value: -54203000 USD 2018-01-01 – 2018-12-31: -54203000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2018-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -54203000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54203000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491305 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	USD 21,000 Exact value Exact value: 21000 USD 2018-01-01 – 2018-12-31: 21000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2018-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 21000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2535645 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	−USD 54.22 million Calculation and evidence -54203000 − 21000 USD Exact free cash flow: -54224000 USD 2018-01-01 – 2018-12-31: -54203000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 21000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2018-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -54224000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -54203000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491305 Filing: 000119312520302986 Input fundies:CapitalExpenditure: 21000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2535645 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 24.52 million Exact value Exact value: -24522000 USD 2019-01-01 – 2019-12-31: -24522000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2019-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -24522000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24522000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491495 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	−USD 23.74 million Exact value Exact value: -23737000 USD 2019-01-01 – 2019-12-31: -23737000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2019-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -23737000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23737000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491115 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	USD 26,000 Exact value Exact value: 26000 USD 2019-01-01 – 2019-12-31: 26000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2019-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 26000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2535459 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.	−USD 23.76 million Calculation and evidence -23737000 − 26000 USD Exact free cash flow: -23763000 USD 2019-01-01 – 2019-12-31: -23737000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 26000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2019-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -23763000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23737000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2491115 Filing: 000119312520302986 Input fundies:CapitalExpenditure: 26000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000119312520302986/kmph-20200930.xml#2535459 Filing: 000119312520302986 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 12.76 million Exact value Exact value: -12760000 USD 2020-01-01 – 2020-12-31: -12760000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2020-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -12760000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12760000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm#3207543 Filing: 000143774922007725 The citation records this snapshot. The page link may show a newer release later.	−USD 1.94 million Exact value Exact value: -1939000 USD 2020-01-01 – 2020-12-31: -1939000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2020-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -1939000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1939000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm#2270347 Filing: 000143774922007725 The citation records this snapshot. The page link may show a newer release later.	USD 33,000 Exact value Exact value: 33000 USD 2020-01-01 – 2020-12-31: 33000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2020-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 33000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm#2273537 Filing: 000143774922007725 The citation records this snapshot. The page link may show a newer release later.	−USD 1.97 million Calculation and evidence -1939000 − 33000 USD Exact free cash flow: -1972000 USD 2020-01-01 – 2020-12-31: -1939000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 33000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2020-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -1972000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1939000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm#2270347 Filing: 000143774922007725 Input fundies:CapitalExpenditure: 33000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm#2273537 Filing: 000143774922007725 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 8.56 million Exact value Exact value: -8555000 USD 2021-01-01 – 2021-12-31: -8555000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2021-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -8555000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8555000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm#2450154 Filing: 000143774923005703 The citation records this snapshot. The page link may show a newer release later.	USD 10.44 million Exact value Exact value: 10439000 USD 2021-01-01 – 2021-12-31: 10439000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2021-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: 10439000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10439000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm#1773713 Filing: 000143774923005703 The citation records this snapshot. The page link may show a newer release later.	USD 102,000 Exact value Exact value: 102000 USD 2021-01-01 – 2021-12-31: 102000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2021-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 102000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 102000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm#1778832 Filing: 000143774923005703 The citation records this snapshot. The page link may show a newer release later.	USD 10.34 million Calculation and evidence 10439000 − 102000 USD Exact free cash flow: 10337000 USD 2021-01-01 – 2021-12-31: 10439000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 102000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2021-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: 10337000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10439000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm#1773713 Filing: 000143774923005703 Input fundies:CapitalExpenditure: 102000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm#1778832 Filing: 000143774923005703 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 26.77 million Exact value Exact value: -26772000 USD 2022-01-01 – 2022-12-31: -26772000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2022-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -26772000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26772000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm#4641191 Filing: 000143774924010430 The citation records this snapshot. The page link may show a newer release later.	−USD 18.72 million Exact value Exact value: -18717000 USD 2022-01-01 – 2022-12-31: -18717000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2022-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -18717000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18717000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm#1898026 Filing: 000143774924010430 The citation records this snapshot. The page link may show a newer release later.	USD 93,000 Exact value Exact value: 93000 USD 2022-01-01 – 2022-12-31: 93000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2022-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 93000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 93000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm#1903609 Filing: 000143774924010430 The citation records this snapshot. The page link may show a newer release later.	−USD 18.81 million Calculation and evidence -18717000 − 93000 USD Exact free cash flow: -18810000 USD 2022-01-01 – 2022-12-31: -18717000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 93000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2022-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -18810000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18717000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm#1898026 Filing: 000143774924010430 Input fundies:CapitalExpenditure: 93000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm#1903609 Filing: 000143774924010430 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 46.05 million Exact value Exact value: -46049000 USD 2023-01-01 – 2023-12-31: -46049000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2023-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -46049000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46049000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm#2533903 Filing: 000143774925007320 The citation records this snapshot. The page link may show a newer release later.	−USD 33.54 million Exact value Exact value: -33535000 USD 2023-01-01 – 2023-12-31: -33535000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2023-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -33535000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33535000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm#1816969 Filing: 000143774925007320 The citation records this snapshot. The page link may show a newer release later.	USD 296,000 Exact value Exact value: 296000 USD 2023-01-01 – 2023-12-31: 296000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2023-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 296000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 296000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm#1822674 Filing: 000143774925007320 The citation records this snapshot. The page link may show a newer release later.	−USD 33.83 million Calculation and evidence -33535000 − 296000 USD Exact free cash flow: -33831000 USD 2023-01-01 – 2023-12-31: -33535000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 296000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2023-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -33831000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33535000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm#1816969 Filing: 000143774925007320 Input fundies:CapitalExpenditure: 296000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm#1822674 Filing: 000143774925007320 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 105.51 million Exact value Exact value: -105511000 USD 2024-01-01 – 2024-12-31: -105511000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2024-12-31 KEMPHARM, INC (edgar:1434647) Net Income: -105511000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -105511000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1637606 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 69.67 million Exact value Exact value: -69665000 USD 2024-01-01 – 2024-12-31: -69665000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2024-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -69665000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -69665000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1048191 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2024-01-01 – 2024-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2024-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1050384 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 69.67 million Calculation and evidence -69665000 − 0 USD Exact free cash flow: -69665000 USD 2024-01-01 – 2024-12-31: -69665000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2024-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -69665000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -69665000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1048191 Filing: 000143464726000011 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1050384 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 83.23 million Exact value Exact value: 83229000 USD 2025-01-01 – 2025-12-31: 83229000 USD Inspect Net Income Open source Share or cite Citation for Net Income · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Net Income: 83229000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 83229000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1636837 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 1.6 million Exact value Exact value: -1598000 USD 2025-01-01 – 2025-12-31: -1598000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Operating Cash Flow: -1598000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1598000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1047540 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	USD 835,000 Exact value Exact value: 835000 USD 2025-01-01 – 2025-12-31: 835000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Capital Expenditure: 835000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 835000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1049826 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.	−USD 2.43 million Calculation and evidence -1598000 − 835000 USD Exact free cash flow: -2433000 USD 2025-01-01 – 2025-12-31: -1598000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 835000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KEMPHARM, INC · 2025-12-31 KEMPHARM, INC (edgar:1434647) Free cash flow: -2433000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T02:21:41Z Snapshot: cce3f0b2e912fc40a0933f211ede70284a5c8934f6e2e0b7ed69a799a5012e2e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1434647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1598000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1047540 Filing: 000143464726000011 Input fundies:CapitalExpenditure: 835000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm#1049826 Filing: 000143464726000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

60 filings · 3,275 latest values · 3,275 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001434647, 1434647, KMPH, ZVRA, edgar:1434647, kmph

Also known as KEMPHARM INC, KEMPHARM, INC, ZEVRA THERAPEUTICS, INC., Zevra Therapeutics, Inc.

KEMPHARM, INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation